AHA 2022 Conference Coverage
M

AHA 2022: Genomic Therapies for Hereditary Transthyretin (TTR) Amyloidosis

By AHA 2022 Conference Coverage FEATURING Marianna Fontana
By AHA 2022 Conference Coverage FEATURING Marianna Fontana
274 views
November 29, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
16:45
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

Feat. S. Lentzsch
10:09
Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
17:29
UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
40:17
American College of Cardiology

Heart Failure with Preserved Ejection Fraction: Current Perspectives…

Feat. S. Shah
14:18
CCM® Therapy

The CCM Solution: How Does it Work and What Does it Do?

Feat. N. Varma
28:03
Houston Methodist DeBakey Heart and Vascular Center

How to Detect and Treat Heart Failure with Preserved Ejection Fracti…

16:11
Jeffrey Weitz

Extended Anticoagulation for VTE

11:50
American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson
19:30
American Heart & Vascular Institute

ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…

Feat. B. Reddy
21:36
NYU Langone

Emerging Therapies in Cardiac Amyloidosis

Feat. M. Hanna
23:19
UChicago Medicine

Amyloidosis: The Forgotten Protein

Feat. N. Sarswat
12:21
CVRx | Barostim

Baroreflex Activation Therapy Overview of Clinical Data

Feat. L. Tsao
12:14
CVRx | Barostim

HFA 2023: Challenges and Unmet Needs in GDMT for HFrEF

Feat. J. Lindenfeld
54:29
Terumo Interventional Systems

Re-thinking Patient-Centered Care in Cardiology-Heart Failure Evalua…

Feat. J. Spertus